Emergent Biosolutions (EBS)
(Delayed Data from NYSE)
$13.81 USD
+1.32 (10.57%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $14.00 +0.19 (1.38%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/6/24 |
---|---|
Current Quarter | -0.97 |
EPS Last Quarter | 0.59 |
Last EPS Surprise | NA |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.98 |
Next Year | -1.15 |
EPS (TTM) | -2.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 199.47M | 345.33M | 1.01B | 1.14B |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 199.47M | 345.33M | 1.01B | 1.14B |
Low Estimate | 199.47M | 345.33M | 1.01B | 1.14B |
Year ago Sales | 337.90M | 270.50M | 1.05B | 1.01B |
Year over Year Growth Est. | -40.97% | 27.66% | -4.21% | 13.12% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.97 | 0.32 | -1.98 | -1.15 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.97 | 0.32 | -1.98 | -1.15 |
Low Estimate | -0.97 | 0.32 | -1.98 | -1.15 |
Year ago EPS | -1.06 | -1.44 | -6.23 | -1.98 |
Year over Year Growth Est. | 8.49% | 122.22% | 68.22% | 41.92% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.97 | 0.32 | -1.98 | -1.15 |
7 Days Ago | -0.97 | 0.32 | -1.98 | -1.15 |
30 Days Ago | -0.97 | 0.32 | -1.98 | -1.15 |
60 Days Ago | -0.97 | 0.32 | -1.98 | -1.15 |
90 Days Ago | -5.15 | -4.71 | -13.98 | -0.25 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.97 | 0.32 | -1.98 | -1.15 |
Zacks Consensus Estimate | -0.97 | 0.32 | -1.98 | -1.15 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.59 | -0.77 | -1.44 | -1.06 | NA |
Estimate | NA | -0.33 | -0.12 | -0.98 | NA |
Difference | NA | -0.44 | -1.32 | -0.08 | -0.61 |
Surprise | NA | -133.33% | -1,100.00% | -8.16% | -413.83% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more